Products
Online Inquiry
Dazmegrel
Cat. No.:
0225LY-0929
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Dazmegrel is a specific and potent thromboxane A2 (TXA2) synthase inhibitor used to prevent excessive platelet aggregation during normal pregnancy.
Synonym:
UK-38,485; UK 38485; UK38,485; UK-38485; 76894-77-4; 3-(Imidazol-1-ylmethyl)-2-methylindole-1-propionic acid; 1H-Indole-1-propanoic acid, 3-(1H-imidazol-1-ylmethyl)-2-methyl-; 1H-Indole-1-propanoicacid, 3-(1H-imidazol-1-ylmethyl)-2-methyl-; Dazmegrelum; 3-[3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indol-1-yl]propanoic acid
CAS No.:
76894-77-4
Compound CID:
53555
Formula:
C16H17N3O2
Formula Weight:
283.33
Specification
Relative Density:
1.26 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dazmegrel can be used in cardiovascular research to study the selective inhibition of thromboxane synthase.
Library Information
Target:
TXAS
Receptor:
TXA2R
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
h10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
